SUDEEP PHARMA
Quarterly Results Analysis [Mar2026]
SUDEEP PHARMA Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|
| Revenues | ₹182 Cr | ₹172 Cr | ₹163 Cr | ₹158 Cr | ₹116 Cr | ₹149 Cr |
| Expenses | ₹120 Cr | ₹112 Cr | ₹107 Cr | ₹99 Cr | ₹76 Cr | ₹85 Cr |
| Operating Income | ₹63 Cr | ₹60 Cr | ₹55 Cr | ₹59 Cr | ₹39 Cr | ₹63 Cr |
| Other Income | ₹6 Cr | ₹7 Cr | ₹10 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr |
| Interest | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
| Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Profit Before Tax | ₹63 Cr | ₹62 Cr | ₹60 Cr | ₹58 Cr | ₹38 Cr | ₹62 Cr |
| Profit After Tax | ₹49 Cr | ₹48 Cr | ₹47 Cr | ₹44 Cr | ₹29 Cr | ₹49 Cr |
| EPS | ₹4.33 | ₹4.20 | ₹4.71 | ₹4.54 | ₹2.95 | ₹0.50 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUDEEP PHARMA | 2.6% | 29.9% | NA |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -2.3% | 8% |
| DIVIS LABORATORIES | 2% | -2.2% | 1.5% |
| TORRENT PHARMACEUTICALS | -1.8% | -0.1% | 36.7% |
| CIPLA | -2% | -3.3% | -9.9% |
| DR REDDYS LABORATORIES | -0.6% | -3.8% | -6.9% |
| MANKIND PHARMA | 1.5% | -6.4% | 1% |
| LUPIN | 3.5% | 3% | 16.4% |
| ZYDUS LIFESCIENCES | -1.6% | 2.9% | 10.2% |
SUDEEP PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 5.80 % |
| Y-o-Y | 57.82 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹182 Cr | 5.80 | |
| Dec2025 | ₹172 Cr | 5.94 | |
| Sep2025 | ₹163 Cr | 3.25 | |
| Mar2025 | ₹158 Cr | 36.36 | |
| Dec2024 | ₹116 Cr | -22.35 | |
| Sep2024 | ₹149 Cr | - | |
SUDEEP PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 4.38 % |
| Y-o-Y | 59.30 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹63 Cr | 4.38 | |
| Dec2025 | ₹60 Cr | 8.13 | |
| Sep2025 | ₹55 Cr | -5.64 | |
| Mar2025 | ₹59 Cr | 49.58 | |
| Dec2024 | ₹39 Cr | -38.09 | |
| Sep2024 | ₹63 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -1.35 % |
| Y-o-Y | 0.94 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 34.33% | -1.35 | |
| Dec2025 | 34.8% | 2.05 | |
| Sep2025 | 34.1% | -8.60 | |
| Mar2025 | 37.31% | 9.70 | |
| Dec2024 | 34.01% | -20.28 | |
| Sep2024 | 42.66% | - | |
SUDEEP PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 1.76 % |
| Y-o-Y | 69.06 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹49 Cr | 1.76 | |
| Dec2025 | ₹48 Cr | 1.97 | |
| Sep2025 | ₹47 Cr | 5.87 | |
| Mar2025 | ₹44 Cr | 53.90 | |
| Dec2024 | ₹29 Cr | -41.10 | |
| Sep2024 | ₹49 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -3.83 % |
| Y-o-Y | 7.12 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 26.62 % | -3.83 | |
| Dec2025 | 27.68 % | -3.76 | |
| Sep2025 | 28.76 % | 2.53 | |
| Mar2025 | 28.05 % | 12.88 | |
| Dec2024 | 24.85 % | -24.15 | |
| Sep2024 | 32.76 % | - | |
SUDEEP PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 3.10 % |
| Y-o-Y | 46.78 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.33 | 3.10 | |
| Dec2025 | ₹4.2 | -10.83 | |
| Sep2025 | ₹4.71 | 3.74 | |
| Mar2025 | ₹4.54 | 53.90 | |
| Dec2024 | ₹2.95 | 490.00 | |
| Sep2024 | ₹0.5 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD